Therapy Areas: Oncology
Personal Genome Diagnostics, Cleveland Clinic Collaborate to Expand Utility of Liquid Biopsy Applications in Oncology Clinical Research
21 September 2021 - - US-based cancer genomics specialist Personal Genome Diagnostics Inc has forged a collaboration with the Center for Immunotherapy and Precision Immuno-Oncology and the Cleveland Clinic Lerner Research Institute, Cleveland, Ohio, the company said.

Both parties will collaborate to enhance capabilities within elio plasma complete reporting, as well as collaborate on the development of proprietary methods for complex biomarker detection and assay iterations to meet emerging liquid biopsy applications in solid tumors.

This strategic collaboration combines Cleveland Clinic's world-class research and commitment to innovation with the comprehensive PGDx portfolio and actionable genomic information.

Both organizations are driven to elevate the standard of care for patients and increase utilization of precision diagnostics within the cancer care continuum.

The CITI ctDNA team will work closely with the Cleveland Clinic Taussig Cancer Institute and the Pathology and Laboratory Medicine Institute to accelerate progress in ctDNA work in cancer patients.

This effort is a partnership with Jame Abraham, M.D., Interim chair, Cleveland Clinic Taussig Cancer Institute and Brian Rubin, M.D., chairman of the Pathology and Laboratory Medicine Institute at Cleveland Clinic.

Personal Genome Diagnostics empowers the fight against cancer by unlocking actionable information from the genome.

PGDx was established by researchers from Johns Hopkins University who are pioneers in cancer genome sequencing and liquid biopsy technologies.

PGDx's elio Platform has enabled the development of standardized tissue-based and liquid biopsy next-generation sequencing kits for laboratories worldwide, featuring automated bioinformatics that ensures consistent results and quality of testing.

By automating the data analysis process, PGDx is enabling the scalability of precision medicine with a fast, reliable, and accurate diagnostics platform.


Related Headlines